Page 2387 - Cote clinical veterinary advisor dogs and cats 4th
P. 2387

1180  Urethral Stent Placement




                                                R
  VetBooks.ir  CANINE ABDOMEN















                                                                URETHRAL STENT PLACEMENT  Two urethral stents were placed in a male
                                                                cat with sustained urethral spasm. One year later, the cat received several enemas
           URETHRAL STENT PLACEMENT  Urethral stent placed in a female dog with   due to constipation. After the procedure, it was found that his urine stream had
           urethral and substantial trigonal transitional cell carcinoma. The stent is visible as   decreased. A radiograph revealed complications involving both stents. The cranial-most
           a fine mesh tube over and cranial to the pubis; several filling defects in the trigone   stent had migrated into the bladder (white arrow), and the stent remaining in the
           region are caused by the neoplastic mass.            urethra was damaged (fractured and flattened, black arrows). This case illustrates
                                                                the importance of a careful, gentle approach when performing certain manipulations
                                                                (enemas, rectal palpation, rectal temperature) in animals that have urethral stents.


           •  An  appropriately  sized  introducer  sheath   0.5-1 cm  both  cranial  and  caudal  to  the   Alternatives and Their
            (usually 8 Fr) is slid along the guide wire   obstruction.           Relative Merits
            into the distal urethra.          •  The stent is passed over the guide wire and   •  Urethral catheterization: short-term option
           Contrast cystourethrogram:           into position under fluoroscopic guidance   to relieve urethral obstruction
           •  In  females,  this  can  be  done  through  the   and then deployed.  •  Cystostomy  tube:  the  tube  can  be  placed
            introducer sheath with the HGW in place.  •  The stent is not reconstrainable, and after   by a percutaneous approach or surgically
           •  In  male  dogs,  a  Berenstein  catheter  is   deployment has been initiated, it cannot be   and emptied by the owner 2-3 times/day;
            advanced over the HGW and through the   stopped or replaced.           no incontinence, high rate of urinary tract
            introducer sheath that has been sutured to   •  Patency  is  verified  by  performing  another   infections
            the  prepuce.  The  HGW  is  removed,  and   contrast cystourethrogram.  •  Manual bladder evacuation at home: requires
            contrast (50 : 50 mixture of iodinated contrast   •  The stent delivery system, the sheath, HGW,   dedicated and skilled owner, risk of bladder
            and 0.9% sterile saline) is injected through   and marker catheter are withdrawn.  trauma/rupture; some patients with complete
            the Berenstein catheter.          •  If the urethra cannot be catheterized (e.g.,   urethral  obstruction  cannot  be  manually
           •  Contrast is injected into the urinary bladder   obstructive  urethral  transitional  cell  carci-  emptied
            to ensure full bladder distention, allowing   noma), an antegrade approach through the
            clear distinction between the urethra, trigone,   bladder can be used to pass the HGW and   Pearls
            and bladder.                        gain access to the bladder and urethra. In   •  Good  bladder  filling  during  the  voiding
           •  The  catheter  is  then  withdrawn  into  the   male cats, this antegrade approach can be   urethrocystogram is essential because it allows
            proximal urethra, and contrast is continu-  used to pass the stent as the small diameter   identification  of  the  urethra  and  trigone.
            ously injected while withdrawing the catheter   of  the  penile  urethra  prevents  retrograde   Placing a stent in the trigone is inappropriate
            under fluoroscopic guidance. The catheter is   passage of the stent.   and may result in stent migration into the
            withdrawn to the distal portion of the urethra                         bladder.
            (in males) or the vestibule (in females while   Postprocedure        •  A longer stent is easier to place and more
            maintaining HGW access).          •  Patients can be discharged the same day.  likely to span the obstructed area.
           •  The site and length of the obstruction can   •  Long-standing urethral obstruction can be   •  There is no association between the length of
            be determined along with measurement of   associated with bladder atony. Bethanechol   the stent placed and the incontinence rate.
            the maximal urethral diameter.      5-15 mg/DOG total dose PO q 8h for 7-10   •  No  predictors  of  incontinence  have  been
           •  A  voiding  cystourethrogram  (manually   days  after  the  procedure  can  assist  in  re-  identified.
            compressing the bladder under fluoroscopic   establishing detrusor function.
            guidance) can further assist in visualizing the   •  Analgesia:  nonsteroidal  antiinflammatory   RELATED CLIENT EDUCATION
            obstruction, but radiation safety principles   drugs (NSAIDs), buprenorphine, or tramadol
            must  be  respected  (i.e.,  keep  compressing   can be administered for 4-5 days after the   SHEETS
            hand away from x-ray beam).         procedure.
           Stent selection:                     ○   NSAIDs can be part of a chemotherapy   Consent to Perform General Anesthesia
           •  A diameter stent 10%-15% greater than the   protocol for transitional cell and prostatic   Prostatic Diseases
            maximal diameter of the urethra near the   carcinoma.                AUTHOR: Marilyn Dunn, DMV, MVSc, DACVIM
            obstruction is selected.          •  Ongoing  chemotherapy  is  indicated  in   EDITORS: Leah A. Cohn, DVM, PhD, DACVIM; Mark S.
           •  The length of the obstruction is calculated,   the  presence  of  bladder/urethral/prostatic   Thompson, DVM, DABVP
            and  the  stent  length  is  chosen  to  extend   neoplasia (stent only palliative).






                                                     www.ExpertConsult.com
   2382   2383   2384   2385   2386   2387   2388   2389   2390   2391   2392